Allergan Can't Escape Generic Drug Price-Fixing Suit

By Reenat Sinay (August 6, 2019, 6:43 PM EDT) -- Allergan must face a proposed class action accusing the pharmaceutical company of taking part in a generic drug price-fixing scheme after a New Jersey federal judge rejected the company's dismissal bid Tuesday, finding its investors convincingly contended that Allergan violated federal antitrust and securities laws....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!